Amyotrophic Lateral Sclerosis Als Clinical Trials

2 clinical trials found for Amyotrophic Lateral Sclerosis Als.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials for Amyotrophic Lateral Sclerosis Als

A Phase IIB Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Study to Evaluate the Effects of PHENOGENE-1A (Cromolyn) as an Adjuvant Treatment in Subjects With Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)

NCT07142291 · RECRUITING · Phase 2

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT07161999 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Amyotrophic Lateral Sclerosis Als?

There are 2 clinical trials listed for Amyotrophic Lateral Sclerosis Als. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Amyotrophic Lateral Sclerosis Als trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Amyotrophic Lateral Sclerosis Als trials in?

Current Amyotrophic Lateral Sclerosis Als trials are distributed across: Phase 2 (2).

Find More Trials